Hudson Bay Capital Management LP X4 Pharmaceuticals, Inc Transaction History

Hudson Bay Capital Management LP

  • $21.9 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$0.58 - $1.47 $131,802 - $334,051
227,246 New
227,246 $131,000
Q4 2021

Feb 14, 2022
SELL
$1.9 - $5.6 $87,196 - $257,000
-45,893 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$4.53 - $6.45 $573,135 - $816,054
-126,520 Reduced 73.38%
45,893 $243,000
Q1 2021

May 14, 2021
BUY
$6.63 - $10.28 $1.14 Million - $1.77 Million
172,413 New
172,413 $1.38 Million

Others Institutions Holding XFOR

# of Institutions
105
Shares Held
100M
Call Options Held
213K
Put Options Held
50.6K
View Full List

About X4 Pharmaceuticals, Inc

XFOR Quotes by TradingView
  • Ticker XFOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,646,096
  • Market Cap $23.3M
  • Description
  • X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...
More about XFOR
Track This Portfolio

Track Hudson Bay Capital Management LP Portfolio

Follow Hudson Bay Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email